Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Publications

Showing entries 1 - 5 out of 307
Dvorak, V, Casiraghi, A, Colas, C, Koren, A, Tomek, T, Offensperger, F, Rukavina, A, Tin, G, Hahn, E, Dobner, S, Frommelt, F, Boeszoermenyi, A, Bernada, V, Hannich, JT, Ecker, GF, Winter, GE, Kubicek, S & Superti-Furga, G 2023, 'Paralog-dependent isogenic cell assay cascade generates highly selective SLC16A3 inhibitors', Cell Chemical Biology, vol. 30, no. 8, pp. 953-964.e9. https://doi.org/10.1016/j.chembiol.2023.06.029

Activities

P-glycoprotein - design of inhibitors and prediction of substrates

Gerhard Ecker
Talk or oral contribution
11.9.2007 - 11.9.2007

Vortrag auf Kongress: Recent developments in physics of fundamental interactions

Gerhard Ecker
XXXI International Conference of Theoretical Physics Matter to the deepest: Recent Developments in Physics of Fundamental Interaction
Conference, Talk or oral contribution
5.9.2007 - 5.9.2007

Multispecificity of drug transporter - probing inhibitor selectivity for the human drug efflux transporter ABCB1 and ABCG2

Gerhard Ecker
Talk or oral contribution
27.8.2007 - 27.8.2007

Chemigenomics and Drug Discovery

Gerhard Ecker
32nd FEBS Congress Molecular Machines, Wien 2007
Conference, Talk or oral contribution
9.7.2007 - 9.7.2007

P-glycoprotein - from target to antitarget

Gerhard Ecker
Talk or oral contribution
28.6.2007 - 28.6.2007